LQDA Stock: Price, Earnings History and SEC Filings
Liquidia Corporation (LQDA) last traded at $45.06, up 0.16% on the latest session and up 48.9% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.74 against an analyst estimate of $0.70, a beat of 5.7%.
$45.06 +0.16%
1 month+48.91%
52-week high$93.61
52-week low$22.21
Volume2.09M
ExchangeNasdaqCM
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
LQDA earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 12, 2026 | $0.74 | $0.70 | +5.71% |
| Mar 2026 | May 11, 2026 | $0.52 | $0.34 | +52.94% |
| Dec 2025 | Mar 5, 2026 | $0.15 | $0.08 | +87.50% |
| Sep 2025 | Nov 3, 2025 | $-0.04 | $-0.45 | +91.11% |
LQDA beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for LQDA
SEC filing data is not available right now. You can search for LQDA on SEC EDGAR.
LQDA news
- Why Did Insmed Stock Jump?Oct 30, 2026 · trefis.com
- Stoke Therapeutics, Inc. (STOK) Reports Q3 Loss, Tops Revenue EstimatesOct 29, 2026 · finance.yahoo.com
- What Is Behind Liquidia's Lead Over Its Industry?Oct 29, 2026 · trefis.com
- Liquidia Gears Up to Report Q3 Earnings: What Can Investors Expect?Oct 28, 2026 · finance.yahoo.com
- EyePoint (EYPT) Expected to Beat Earnings Estimates: Should You Buy?Oct 28, 2026 · finance.yahoo.com
- Liquidia Corporation (LQDA) Earnings Expected to Grow: Should You Buy?Oct 26, 2026 · finance.yahoo.com
- Can Liquidia (LQDA) Still Justify Its Price After Settlement?Oct 24, 2026 · finance.yahoo.com
- United Therapeutics' Tyvaso Outlook Faces Near-Term Pressure After Liquidia Settlement, RBC SaysOct 22, 2026 · finance.yahoo.com
About Liquidia Corporation
Liquidia Corporation (LQDA) is a US-listed public company on Nasdaq.